Le séminaire donnera un aperçu du travail de l’ONUDC sur le traitement des troubles liés à l’usage de drogues, en mettant l’accent sur les efforts visant à soutenir la collaboration en matière de santé et de justice afin d’accroître l’accès...
Rychlá, K., & Šťastná, L. (2022). Psychoactive prescription drug abuse: Selected psychological symptoms and quality of life in addictiontreatment. Study protocol. Adiktologie, 22(4), 258–263. https://doi.org/10.35198/01-2022-004-0002
BACKGROUND: The abuse of psychoactive prescription drugs has become increasingly common in the Czech Republic. These drugs include sedatives, hypnotics, anxiolytics (benzodiazepines and Z-hypnotics), and opioids. Patients with an addiction to these prescription drugs exhibit symptoms associated with long-term use, particularly psychological and somatic problems, sleep disturbances, impaired cognitive functioning, and irritability. There is a need for a flexible response to their needs.
AIMS: The aim of the research is to describe selected psychological symptoms and the quality of life of...
Riegel, K. D. (2022). Bion’s basic assumption groups in the regimen treatment of addictions: Clinical implications. Adiktologie, 22(4), 250–256. https://doi.org/10.35198/01-2022-004-0004
This article provides reflection on the potential application of Bion’s model of basic assumption groups in patients undergoing midterm inpatient addiction treatment. The clinical implications are discussed in terms of the usability of Bion’s model and its possible benefits for patients in regimen addiction treatment, as well as the pitfalls associated with its application in this treatment modality. Despite the highly theoretical nature of this model, clinical experience to date confirms that analysis of the underlying assumptions and associated protomental patterns can provide valuable...
Cette formation en direct sur l’entretien motivationnel a lieu chaque semaine le jeudi de 10h à 11h SAST aux dates suivantes : 9, 16, 23 et 30 mars 2023.
L’entrevue motivationnelle est une approche fondée sur les meilleures données probantes pour lutter contre la consommation de substances nocives et les changements généraux liés à la motivation, y compris la non-observance du traitement. C’est une approche qui ne cherche pas à se substituer à d’autres approches thérapeutiques, mais qui cherche plutôt à les soutenir et à les renforcer.
Nous vous recommandons fortement de suivre cette visite...
This training on Screening Brief Intervention, and Referral to Treatment (SBIRT) for harmful substance use takes place weekly on Thursdays from 12 noon till 1pm SAST on the following dates: 9, 16, 23, 30 March & 6 April 2023.
Source: Shapiro, C. J., Watson MacDonell, K., & Moran, M. (2021). Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review. Implementation Research and Practice. https://doi.org/10.1177/2633489520988258 Plain language abstract: Provider self-efficacy is known...
Vous êtes invités à assister à ce webinaire que la CICAD co-organise avec la Suède le 16 février 2023. Des services d’interprétation en anglais et en espagnol sont assurés.
Substance Abuse and Mental Health Services Administration (SAMHSA)
Ce guide met en évidence les stratégies permettant aux fournisseurs de services de santé comportementale et de logement de mener des activités de sensibilisation et de mobilisation auprès des personnes en situation d’itinérance, d’amorcer l’utilisation d’un traitement de santé comportementale en attendant de recevoir un logement stable et de les retenir dans leurs efforts de rétablissement une fois logés.
Ce guide contient un avant-propos et cinq chapitres. Chaque chapitre est conçu pour être bref et accessible aux administrateurs de programmes, aux cliniciens, au personnel de soins directs...
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022).
Introduction
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.
Method
Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily quantity of...
Hall, K., Higgins, F., Beach, K.F. et al. Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19. Subst Abuse Treat Prev Policy 17, 73 (2022). https://doi.org/10.1186/s13011-022-00499-7
Arrière-plan
La COVID-19 a considérablement limité l’ampleur et la portée du travail des services de santé locaux, en réorientant les ressources vers la riposte. Cependant, le besoin de services de santé publique essentiels, y compris la prévention de la toxicomanie, n’a pas diminué.
Méthode
Six sources de données quantitatives, recueillies entre 2016 et 2021, ont été examinées afin d’explorer l’impact de la pandémie de COVID-19 sur les services liés à la consommation de substances liées à la LHD.
Résultats
Avant la pandémie, la proportion de LHD offrant un certain niveau de services de...
Plus de deux cents parties prenantes philippines et étrangères ont récemment adopté la Déclaration de Manille sur la création de systèmes alternatifs à l’incarcération (ATI) aux Philippines
This anonymous survey addresses the topic of transparency and governance in drug treatment systems. It is part of a broader project coordinated by researchers at the University of Vienna and Universitat de Barcelona. In the following section, you will find all the information concerning the purpose of this survey as well as data and safety regulations.
The purposes of this questionnaire survey are:
Gather data on trends concerning practices in the provision of drug treatment services that might affect patients’ rights and that could be associated with a lack of transparency and...
Kools, N., Dekker, G.G., Kaijen, B.A.P. et al. Correction: Interdisciplinary collaboration in the treatment of alcohol use disorders in a general hospital department: a mixed-method study. Subst Abuse Treat Prev Policy 17, 64 (2022). https://doi.org/10.1186/s13011-022-00492-0
Background
Interdisciplinary collaborations (i.e., where various disciplines work coordinated and interdependently toward shared goals) are stated to yield higher team effectiveness than multidisciplinary approaches (i.e., where various disciplines work in parallel within their professional boundaries) in somatic health care settings. Nevertheless, research is lacking on interdisciplinary approaches for alcohol use disorder (AUD) treatment of hospitalized patients as these types of approaches are still uncommon. This study aims to evaluate an innovative interdisciplinary AUD treatment...
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022). https://doi.org/10.1186/s13011-022-00493-z
Introduction and aims
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.
Method
Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily quantity...
Hall, K., Higgins, F., Beach, K.F. et al. Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19. Subst Abuse Treat Prev Policy 17, 73 (2022). https://doi.org/10.1186/s13011-022-00499-7
Background
The COVID-19 emergency has tested the public health, medical, and public safety infrastructure of the United States (U.S.) in unprecedented ways. As the focal point for public health in their communities, local health departments (LHDs) were particularly impacted by the pandemic’s onset. The pandemic limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use prevention—was not reduced.
Methods
Six quantitative data sources were examined, collected between...
Are you attending Lisbon Addictions 2022 and want to learn more about the addiction workforce training that is available, and discuss how to enhance it?
Wednesday 23rd November 15:00 - 16:30. Insights Zone 2 (I2)
The aim is to represent the main international training experiences, their target groups, and learning objectives for finding synergies to meet the increasing demand for training. Presentations:
BACKGROUND: Suicide is considered a severeglobal phenomenon as near to 700,000 people die annually as a result of suicidal behaviours. Suicide is a major public health problem among patients with a substance use disorder. AIM: To determine the prevalence of suicidal ideation/behaviours and to...
Ensuring continued learning and offering opportunities to substance use dependence treatment professionals to learn advanced and evidence-based treatment techniques and strategies is one of the important missions of UNODC. In this regard, UNODC Pakistan in collaboration with the Ministry of Narcotics Control and with the generous support from Bureau of International Narcotics and Law Enforcement Affairs, U.S. Department of State, has initiated a training of trainers’ (ToT) programme on the Advanced Universal Treatment Curriculum (UTC) courses 9 -15 for UTC national trainers to be...